Hospira Comes Out $40K Ahead In Verdict Against GSK

Law360, Chicago (May 19, 2017, 5:22 PM EDT) -- An Illinois federal jury concluded on Friday that both GlaxoSmithKline and Hospira were injured by the fallout over a troubled contract to manufacture a flu vaccine and awarded both parties damages, giving Hospira a slight edge of $40,000.

A jury in Chicago deemed a GSK subsidiary responsible for breaching a contract with Hospira. (AP) A jury in Chicago deemed GSK subsidiary Glaxosmithkline Biologicals SA responsible for breaching a contract with Hospira Worldwide Inc., which won $1.35 million in damages for work it performed packaging the vaccine...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.